Neil Formica

2.0k total citations
11 papers, 457 citations indexed

About

Neil Formica is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Neil Formica has authored 11 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Immunology. Recurrent topics in Neil Formica's work include Influenza Virus Research Studies (5 papers), Respiratory viral infections research (5 papers) and Immune Response and Inflammation (3 papers). Neil Formica is often cited by papers focused on Influenza Virus Research Studies (5 papers), Respiratory viral infections research (5 papers) and Immune Response and Inflammation (3 papers). Neil Formica collaborates with scholars based in Australia and United States. Neil Formica's co-authors include Jillian Bennet, Günter Härtel, Maryanne Skeljo, Mary Beers, David Ryan, Katja Höschler, Terry Nolan, Russell L. Basser, Peter Richmond and Maria Zambon and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and PLoS Medicine.

In The Last Decade

Neil Formica

11 papers receiving 431 citations

Peers

Neil Formica

EPIDE

IMMUN

SURGE

M Du Ry van Beest Holle Netherlands

Hope H. Biswas United States

M. A. Chernesky Canada

Stéphane Thomas France

G. Zoulek Germany

Meseret Habtamu Ethiopia

Josephine Bwogi Uganda

Micha Löbermann Germany

Veronika Učakar Slovenia

Gary Grohmann United States

M Du Ry van Beest Holle Netherlands

Neil Formica

228 ×0.8

EPIDE

150 ×0.8

19 ×0.2

IMMUN

55 ×1.1

SURGE

33 ×0.7

Citations per year, relative to Neil Formica Neil Formica (= 1×) peers M Du Ry van Beest Holle

Countries citing papers authored by Neil Formica

Since Specialization

Citations

This map shows the geographic impact of Neil Formica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Formica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Formica more than expected).

Fields of papers citing papers by Neil Formica

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Formica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Formica. The network helps show where Neil Formica may publish in the future.

Co-authorship network of co-authors of Neil Formica

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Formica. A scholar is included among the top collaborators of Neil Formica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Formica. Neil Formica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Formica, Neil, Raburn M. Mallory, Gary Albert, et al.. (2021). Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLoS Medicine. 18(10). e1003769–e1003769. 64 indexed citations

Albano, Frank R., et al.. (2017). Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study. Vaccine. 35(20). 2745–2752. 7 indexed citations

Treanor, John, et al.. (2017). Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study. Vaccine. 35(15). 1856–1864. 29 indexed citations

Talbot, H. Keipp, Wendy A. Keitel, Thomas R. Cate, et al.. (2008). Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 26(32). 4057–4061. 31 indexed citations

Nolan, Terry, Peter Richmond, Maryanne Skeljo, et al.. (2008). Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine. 26(33). 4160–4167. 72 indexed citations

Newall, Anthony T., Julia Brotherton, Helen Quinn, et al.. (2008). Population Seroprevalence of Human Papillomavirus Types 6, 11, 16, and 18 in Men, Women, and Children in Australia. Clinical Infectious Diseases. 46(11). 1647–1655. 73 indexed citations

Nolan, Terry, Peter Richmond, Neil Formica, et al.. (2008). Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine. 26(50). 6383–6391. 82 indexed citations

Gilroy, Nicole, et al.. (2001). Abattoir‐associated Q fever: a Q fever outbreak during a Q fever vaccination program. Australian and New Zealand Journal of Public Health. 25(4). 362–367. 32 indexed citations

Formica, Neil, et al.. (2001). The impact of diagnosis by legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease. Epidemiology and Infection. 127(2). 275–280. 43 indexed citations

10.

Silagy, Chris & Neil Formica. (2001). Place of bupropion in smoking-cessation therapy. The Lancet. 357(9268). 1550–1550. 11 indexed citations

11.

Formica, Neil, Graham Tallis, John Carnie, et al.. (2000). Legionnaires' disease outbreak: Victoria's largest identified outbreak. Communicable Diseases Intelligence. 24(7). 199–202. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact